Table 3.

Estimated effects for secondary outcomes comparing statin and placebo periods (from participant questionnaire) for aspects of daily life (n=152)

	Mean difference, cm (99% CI)
General activity	0.09 (−0.25 to 0.42)
Mood	0.26 (−0.04 to 0.56)
Ability to walk	0.11 (−0.22 to 0.43)
Normal work	0.15 (−0.17 to 0.46)
Relationships with other people	0.15 (−0.09 to 0.39)
Sleep	−0.02 (−0.32 to 0.29)
Enjoyment of life	0.13 (−0.22 to 0.48)

Each analysis includes all participants with at least one measurement for that outcome during a placebo period and at least one measurement during a statin period. One additional participant provided secondary outcome data through our questionnaire than provided primary outcome data. Values greater than zero indicate more symptoms on statins.